|
⚲
|
| Keyboard |
| Kuwahara Jon
✚
|
|
|---|---|
| CIK # | 0001664784 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001664784] | |
| 4 | [0001664784] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| CNS Response Inc | |
| Kuwahara Jon | |
| Tokai Pharmaceuticals Inc | |
| Emmaus Life Sciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tokai Pharmaceuticals Inc NVUS
Stock Option (Right to Buy) · derivative
|
2020-09-11 | Grant | 2,145.26 | $0.00 | |
|
Tokai Pharmaceuticals Inc NVUS
Stock Option (Right to Buy) · derivative
|
2020-03-19 | Grant | 50,000 | $0.00 | |
|
Tokai Pharmaceuticals Inc NVUS
Stock Option (Right to Buy) · derivative
|
2019-09-26 | Grant | 60,000 | $0.00 | |
|
Tokai Pharmaceuticals Inc NVUS
Common Stock
|
2019-05-21 | Sell | 1,058 | $1.91 | 2,021 |
|
Tokai Pharmaceuticals Inc NVUS
Common Stock
|
2019-05-20 | Sell | 4,218 | $1.96 | 8,267 |
|
Tokai Pharmaceuticals Inc NVUS
Stock Option (Right to Buy) · derivative
|
2019-03-14 | Grant | 25,000 | $0.00 | |
|
Tokai Pharmaceuticals Inc NVUS
Common Stock
|
2018-03-13 | Grant | 11,250 | $0.00 | |
|
Tokai Pharmaceuticals Inc NVUS
Stock Option (Right to Buy) · derivative
|
2018-03-13 | Grant | 12,000 | $0.00 | |
|
Emmaus Life Sciences Inc NONE
Options · derivative
|
2018-02-27 | Grant | 10,000 | $0.00 | |
|
Tokai Pharmaceuticals Inc NVUS
Stock Option (Right to Buy) · derivative
|
2017-07-10 | Grant | 35,000 | $0.00 | |
|
Emmaus Life Sciences Inc EMMA
Options · derivative
|
2016-05-10 | Grant | 100,000 | $0.00 | |
|
Emmaus Life Sciences Inc NONE
Non-Qualified Stock Options · derivative
|
2016-01-14 | Grant | 100,000 | $0.00 |